Recombinant Human IgG2 同型对照
MALS verified
IsoC, ELISA, WB, IHC, NC, IF, in vivo, in vitro
Chimeric
IgG2
Recombinant Antibody
unconjugated
-
- 抗原 See all IgG2 products
- IgG2
- 抗体类型
- Recombinant Antibody
-
宿主
- Human
-
克隆类型
- Chimeric
- 应用范围
- Isotype Control (IsoC), ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Negative Control (NC), Immunofluorescence (IF), In vivo Studies (in vivo), In vitro Assay (in vitro)
- 原理
- Human IgG2 Kappa Isotype Control (mAb, carrier free, MALS verified)
- 特异性
- Specifically reacts with DNP (Dinitrophenyl) and DNP conjugated proteins.
- 产品特性
- Human IgG2 Kappa Isotype Control (mAb) is a chimeric monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which combines the variable region of a mouse monoclonal antibody with human IgG2 constant domain. The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with DNP.
- 质量等级
- MALS verified
- 亚型
- IgG2
-
HEK-293 Cells IgG2 isotype control
IsoC IgG2 unconjugated
-
- 应用备注
- This antibody is suitable for use as a non-targeting isotype control in various in vitro and in vivo studies. It can also be used as a negative control in various applications such as ELISA, Western blot, immunofluorescence, immunohistochemistry
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 储存条件
- -80 °C
- 储存方法
- -70°C
-
- 抗原
- IgG2
- Abstract
- IgG2 产品
- 别名
- FCGR2B Isotype Control, Fc fragment of IgG, low affinity IIb, receptor (CD32) Isotype Control, FCGR2B Isotype Control
- 物质类
- Antibody
- 背景
- A hapten is a small molecule that can elicit an immune response only when conjugated with a large carrier such as a protein. Typical haptens include drugs, urushiol, quinone, steroids, etc. Peptides and non-protein antigens usually need conjugating to a carrier protein (such as BSA (bovine serum albumin) or KLH (keyhole limpet hemocyanin) to become good immunogens). Additionally, haptens should be administered with an adjuvant to ensure a high quality immune response. It is important that the hapten design (preserving greatly the chemical structure and spatial conformation of target compound), selection of the appropriate carrier protein and the conjugation method are key conditions for the desired specificity anti-hapten antibodies. We design anti-hapten antibodies based on the HaptenDB information.
-
You are here:
